Literature DB >> 8318549

Studies on mitochondrial oxidative phosphorylation in permeabilized human skin fibroblasts: application to mitochondrial encephalomyopathies.

R J Wanders1, J P Ruiter, F A Wijburg.   

Abstract

In this report we describe that the functional capacity of the mitochondrial oxidative phosphorylation system can be studied in cultured skin fibroblasts permeabilized with a limited amount of digitonin. By using a variety of different oxidizable substrates, information can be obtained on the functional activity of complex I, for instance, which is important since different diseases in man have recently been identified in which complex I is deficient. The method described may contribute to the biochemical characterization of patients suffering from one of a variety of encephalomyopathies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8318549     DOI: 10.1016/0925-4439(93)90024-u

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

Review 1.  Mitochondrial injury. Lessons from the fialuridine trial.

Authors:  P Honkoop; H R Scholte; R A de Man; S W Schalm
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

2.  Proteomic and metabolomic analyses of mitochondrial complex I-deficient mouse model generated by spontaneous B2 short interspersed nuclear element (SINE) insertion into NADH dehydrogenase (ubiquinone) Fe-S protein 4 (Ndufs4) gene.

Authors:  Dillon W Leong; Jasper C Komen; Chelsee A Hewitt; Estelle Arnaud; Matthew McKenzie; Belinda Phipson; Melanie Bahlo; Adrienne Laskowski; Sarah A Kinkel; Gayle M Davey; William R Heath; Anne K Voss; René P Zahedi; James J Pitt; Roman Chrast; Albert Sickmann; Michael T Ryan; Gordon K Smyth; David R Thorburn; Hamish S Scott
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

3.  Prenatal diagnosis of systemic disorders of the respiratory chain in cultured chorionic villus fibroblasts by study of ATP-synthesis in digitonin-permeabilized cells.

Authors:  R J Wanders; J P Ruiter; F A Wijburg; J Zeman; P Klement; J Houstek
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

4.  Progressive generalized brain atrophy and infantile spasms associated with cytochrome c oxidase deficiency.

Authors:  H D Bakker; C Van den Bogert; J G Drewes; P G Barth; H R Scholte; R J Wanders; W Ruitenbeek
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

5.  Valproate inhibits the mitochondrial pyruvate-driven oxidative phosphorylation in vitro.

Authors:  M F Silva; J P Ruiter; L Illst; C Jakobs; M Duran; I T de Almeida; R J Wanders
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

6.  Antioxidant dysfunction: potential risk for neurotoxicity in ethylmalonic aciduria.

Authors:  Christina B Pedersen; Zarazuela Zolkipli; Søren Vang; Johan Palmfeldt; Margrethe Kjeldsen; Vibeke Stenbroen; Stinne P Schmidt; Ronald J A Wanders; Jos P N Ruiter; Flemming Wibrand; Ingrid Tein; Niels Gregersen
Journal:  J Inherit Metab Dis       Date:  2010-05-05       Impact factor: 4.982

7.  NADH-coenzyme Q reductase (complex I) deficiency: heterogeneity in phenotype and biochemical findings.

Authors:  S Pitkänen; A Feigenbaum; R Laframboise; B H Robinson
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

8.  Mitochondrial oxidative phosphorylation in digitonin-permeabilized chorionic villus fibroblasts: a new method with potential for prenatal diagnosis.

Authors:  R J Wanders; J P Ruiter; F A Wijburg
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

Review 9.  Biochemical diagnosis of mitochondrial disorders.

Authors:  Richard J T Rodenburg
Journal:  J Inherit Metab Dis       Date:  2010-05-04       Impact factor: 4.982

10.  Fenretinide induces mitochondrial ROS and inhibits the mitochondrial respiratory chain in neuroblastoma.

Authors:  Roos Cuperus; René Leen; Godelieve A M Tytgat; Huib N Caron; André B P van Kuilenburg
Journal:  Cell Mol Life Sci       Date:  2009-11-26       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.